Novo Nordisk sees pills capturing over third of GLP-1 obesity market by 2030
Jan 12 (Reuters) - Oral weight-loss drugs could make up a third or more of the overall GLP-1 market...
12th January, 2026
Jan 12 (Reuters) - Oral weight-loss drugs could make up a third or more of the overall GLP-1 market...
12th January, 2026
Jan 12 (Reuters) - British medical products maker Smith & Nephew will buy U.S.-based Integrity Ortho...
12th January, 2026
By James Davey LONDON, Jan 9 (Reuters) - Britain’s major food retailers are beginning to feel the im...
9th January, 2026
Jan 9 (Reuters) - Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy pill through in...
9th January, 2026
By Michael Erman and Maggie Fick NEW YORK/LONDON, Jan 8 (Reuters) - Global drugmakers face a battle...
8th January, 2026
Jan 7 (Reuters) - Former England forward and manager Kevin Keegan has been diagnosed with cancer, hi...
7th January, 2026
LONDON, Jan 7 (Reuters) - GSK's experimental drug to treat chronic hepatitis B infection met the mai...
7th January, 2026
Jan 6 (Reuters) - U.S. private equity firm TPG is close to acquiring UnitedHealth's Optum UK busines...
6th January, 2026
By Alexander Marrow LONDON, Jan 6 (Reuters) - Nestle is recalling specific batches of its SMA, BEBA...
6th January, 2026
By Maggie Fick and Dan Levine LONDON/SAN FRANCISCO, Jan 5 (Reuters) - Danish obesity drugmaker Novo...
5th January, 2026
LONDON, Jan 5 (Reuters) - Britain's medicines regulator said on Monday it was reviewing Novo Nordisk...
5th January, 2026
COPENHAGEN, Jan 5 (Reuters) - Denmark's Novo Nordisk will offer its 1.5 and 4 milligram Wegovy weigh...
5th January, 2026